Delivery Order SPE2DB22D1103-SPE2DB25FH2L6
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for Malarone 250/100 tablets (100 count) valued at $13,434.32 under a firm fixed price arrangement. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and deliver the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Malarone 250/100 (100 tablets) with a ceiling value of $4,303.64. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $9,160.81. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Malarone (atovaquone/proguanil) 250/100 mg tablets in a quantity of 100 tablets. This is a firm fixed price delivery order with a ceiling value of $4,549.56 and an ultimate completion date of October 9, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Malarone 250-100 mg tablets (100-count units) at a contract ceiling value of $1,818.64. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a competitive award with no set-aside designation. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Malarone 250/100 (100 tablets) with a ceiling value of $8,904.81. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Malarone is an antimalarial medication used for malaria prevention and treatment, reflecting the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 30, 2025, for the supply of Malarone 250-100 mg tablets (100-count) with a ceiling value of $8,911.57. This firm fixed-price delivery order is non-competitively set aside and is scheduled for completion by June 2, 2025. The contract is funded through the Defense Medical Supply Chain, a component of the Department of Defense's medical procurement...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Malarone 250-100 mg tablets. The $2,272.56 firm fixed-price delivery order has a completion date of May 1, 2023. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of...
- The Defense Logistics Agency Troop Support Medical awarded a $646.72 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 units of Malarone 62.5-25mg tablets. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between July 17-18, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing DLA medical supply vehicle contract. Amerisourcebergen will...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Malarone 250/100 100S, a pharmaceutical product, with a ceiling value of $11,352.00 and a period of performance through April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor and...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH2L6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $2,022.30. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's federal contract portfolio demonstrates extensive experience delivering a broad spectrum of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for antimalarial medication supports military medical readiness and healthcare requirements, leveraging AmerisourceBergen's established capacity to fulfill specialized pharmaceutical needs through the DLA's medical supply chain network with an ultimate completion date of September 17, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/16/25 |